Creative Biolabs Introduces Advanced Pre-made Oncolytic Virus Services

With tremendous therapeutic potential, oncolytic virus has been studies by worldwide scientists for a long time. As a dynamic biotech company focusing on this field for years, Creative Biolabs now updates pre-made oncolytic virus services for oncolytic virotherapy research.

New York, United States - March 23, 2020 /MarketersMedia/ —

In October 2015, the Food and Drug Administration (FDA) approved the listing of a recombinant herpes simplex virus product named T-vec, indicating the formal recognition of oncolytic virus (OV) for cancer treatment. In September 2017, a report on CELL showed that the combination of T-vec and anti-tumor drug Keytruda could treat melanoma with the tumor remission rate as high as 62%. Since then, the enthusiasm for oncolytic virotherapy and its combination therapy in the biologic world has never faded away.

With the state-of-the-art OV engineering platform, Creative Biolabs provides a series of purified pre-made oncolytic viruses for global clients, including adenovirus, vesicular stomatitis virus, herpes simplex virus and vaccinia virus. An extensive panel of transgenes has been used to modify the OVs to enhance their therapeutic activity in preclinical studies, such as reporter-encoding, cytokine-expressing, immune checkpoint antibody-arming, capsid-modifying, miRNA-expression, etc.

Among all kinds of OVs, Herpes simplex virus has been used for the basic research and clinical trials to apply in various disease areas. Scientists at Creative Biolabs use combined methods of genomic gene deletion, exogenous gene insertion, capsid modification, miRNA modification, promoter and strains selection to explore pre-made herpes simplex virus with high oncolytic efficacy and low toxicity, thus to meet different scientific research demands of worldwide clients.

Another focus of Creative Biolabs is Pre-made Oncolytic Vaccinia Virus, a large, enveloped virus that is considered as the most potential live biotherapeutic agent because of its strong oncolytic efficacy and potent antigen presentation capability that can combine well with its natural oncolytic activities for cancer immunotherapy. At Creative Biolabs, multiple modified purified oncolytic vaccinia virus products derived from different strains are available to cover demands for gene therapy all over the world.

Apart from the aforementioned OVs, Creative Biolabs offers a collection of pre-made OV to choose various transgenes and promoters. Customized OV services are also provided to meet the specific need of the oncolytic virus therapy research with the best prices and fastest turnaround time.
“The partnership with Creative Biolabs is quite delightful. Their oncolytic virus services are highly customized, and the design and construction are quite rapid and accurate.” Introduced by one of the clients of Creative Biolabs.

With years of research in immunotherapy, Creative Biolabs has accumulated an increasing experience in oncology and is able to provide comprehensive services for developing engineered OV, including engineering, construction, in vitro assay for proof-of-concept study, in vivo assay for proof-of-concept study, etc. More information can be reached at https://www.creative-biolabs.com/oncolytic-virus/.

About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs is known as a famous institute and trustworthy supplier in the biotech market. In the field of virotherapy, by integrating the technologies of viral biology, immunology and genetic engineering, scientists of Creative Biolabs have successfully developed the OncoVirapy™ platform, taking advantage of which, Creative Biolabs provides customized, standardized, and reliable oncolytic virus therapy development services for clients globally.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Phone: 16316197922
Website: https://www.creative-biolabs.com

Source URL: https://marketersmedia.com/creative-biolabs-introduces-advanced-pre-made-oncolytic-virus-services/88950856

Source: MarketersMedia

Release ID: 88950856